Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules

BACKGROUND: Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 + 1 scheme at 2 and 4 months (primary immuniza...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Eva, Terrade, Aude, Denizon, Mélanie, Aouiti-Trabelsi, Myriam, Falguières, Michaël, Taha, Muhamed-Kheir, Deghmane, Ala-Eddine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325224/
https://www.ncbi.nlm.nih.gov/pubmed/34330228
http://dx.doi.org/10.1186/s12879-021-06440-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325224/
https://www.ncbi.nlm.nih.gov/pubmed/34330228
http://dx.doi.org/10.1186/s12879-021-06440-w

Ejemplares similares